治疗时间和分支视网膜静脉封闭结果之间的关联
Marie Kitano1,2, Shuichiro Aoki1, Kohdai Kitamoto1
1Department of Ophthalmology, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
International ophthalmology
|August 25, 2024
概括
早期的抗血管内皮生长因子 (VEGF) 治疗分支视网膜静脉封闭 (BVO) 一年后没有影响视力敏度结果. 然而,治疗时间可能会影响BVO所需的干预次数.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 血管疾病 血管疾病
背景情况:
- 分支视网膜静脉封闭 (BVO) 是一种常见的视网膜血管疾病.
- 及时干预对于管理BVO和维护视觉功能至关重要.
研究的目的:
- 研究从发病到初始治疗的时间之间的关联,以及BVO.患者视力敏度或治疗频率的变化.
- 为了确定延迟开始治疗是否会影响视觉结果或所需干预次数.
主要方法:
- 回顾性研究包括39名急性阶段BVO.患者.
- 患者接受了抗血管内皮生长因子 (VEGF) 治疗.
- 根据从治疗开始后28天内或28天后开始治疗的情况,患者被分类.
主要成果:
- 在12个月后,治疗时间和视敏度变化之间没有发现显著的关联.
- 早期开始治疗 (≤28天) 与一年后需要的治疗次数增加有关.
- 首次访问时的中央黄斑厚度也与治疗次数相关.
结论:
- 开始BVO抗VEGF治疗的时间与1年后视力敏度结果无关.
- 延迟治疗可能与在BVO管理中增加后续干预的需求有关.
相关概念视频
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...